about
A review of UHMWPE wear-induced osteolysis: the role for early detection of the immune response.In vivo imaging of particle-induced inflammation and osteolysis in the calvariae of NFκB/luciferase transgenic miceMulti-body simulation of a canine hind limb: model development, experimental validation and calculation of ground reaction forcesCorrelating subjective and objective descriptors of ultra high molecular weight wear particles from total joint prostheses.The metal nanoparticle-induced inflammatory response is regulated by SIRT1 through NF-κB deacetylation in aseptic loosening.Orthopedic gene therapy in 2008.Local effect of IL-4 delivery on polyethylene particle induced osteolysis in the murine calvarium.Emerging ideas: can erythromycin reduce the risk of aseptic loosening?Effects of SU5416 and a vascular endothelial growth factor neutralizing antibody on wear debris-induced inflammatory osteolysis in a mouse model.Vascular endothelial growth factor gene silencing suppresses wear debris-induced inflammation.Endoplasmic reticulum stress-mediated inflammatory signaling pathways within the osteolytic periosteum and interface membrane in particle-induced osteolysisIcariin attenuates titanium-particle inhibition of bone formation by activating the Wnt/β-catenin signaling pathway in vivo and in vitro.Autophagy mediated CoCrMo particle-induced peri-implant osteolysis by promoting osteoblast apoptosis.Femoral osteolysis following total hip replacement.Direct subcutaneous injection of polyethylene particles over the murine calvaria results in dramatic osteolysisRevision joint replacement, wear particles, and macrophage polarization.Biomimetic strategies based on viruses and bacteria for the development of immune evasive biomaterials.Genetic susceptibility to aseptic loosening following total hip arthroplasty: a systematic review.The role of TLR and chemokine in wear particle-induced aseptic loosening.How has the introduction of new bearing surfaces altered the biological reactions to byproducts of wear and modularity?RAW 264.7 co-cultured with ultra-high molecular weight polyethylene particles spontaneously differentiate into osteoclasts: an in vitro model of periprosthetic osteolysis.Titanium particles up-regulate the activity of matrix metalloproteinase-2 in human synovial cells.rna interference targeting p110β reduces tumor necrosis factor-alpha production in cellular response to wear particles in vitro and osteolysis in vivo.Protection against titanium particle-induced osteoclastogenesis by cyclooxygenase-2 selective inhibitor.A novel strontium-doped calcium polyphosphate/erythromycin/poly(vinyl alcohol) composite for bone tissue engineering.Infectious versus non-infectious loosening of implants: activation of T lymphocytes differentiates between the two entities.Probiotics protect mice from CoCrMo particles-induced osteolysis.The effect of osteoprotegerin gene modification on wear debris-induced osteolysis in a murine model of knee prosthesis failure.Curcumin Attenuation of Wear Particle-Induced Osteolysis via RANKL Signaling Pathway Suppression in Mouse Calvarial Model.Type-2 cannabinoid receptor regulates proliferation, apoptosis, differentiation, and OPG/RANKL ratio of MC3T3-E1 cells exposed to Titanium particles.Macrophage integrins modulate response to ultra-high molecular weight polyethylene particles and direct particle-induced osteolysis.Clinical relevance of corrosion patterns attributed to inflammatory cell-induced corrosion: A retrieval study.MALAT1 enhanced the proliferation of human osteoblasts treated with ultra‑high molecular weight polyethylene by targeting VEGF via miR‑22‑5p.Insulin-like growth factors I and II in the aseptic loosening of total hip implants.Inhibitory Effects of Lanthanum Chloride on Wear Particle-Induced Osteolysis in a Mouse Calvarial Model.Lanthanum Chloride Attenuates Osteoclast Formation and Function Via the Downregulation of Rankl-Induced Nf-κb and Nfatc1 Activities.
P2860
Q26741081-BB974816-DD32-4A97-A106-44607F20A727Q28383687-EF1A01CD-A34A-426C-AF44-A7F43114192AQ30492134-7CC47F69-CC8F-4EC4-B65B-1AA9B0B50AE9Q33655320-E6B17570-38AC-4491-9FB7-3880C8D2172FQ33713171-B6243634-E396-41E5-BBE5-779BAFEE42AFQ33713231-9B103B5D-137D-4F3E-A603-C6867EDF660CQ33816055-9EFF9636-6AD5-419A-A956-BBC569A20DE6Q35078775-1BBACBF8-A171-4BE2-B803-80431A9A5633Q35557415-FC57D87F-5397-4615-B269-7C2CDC5290B5Q35574407-48899477-8E2A-45E4-A85E-BF524D82CF2EQ36527014-11176AFF-09B7-4DF3-AD80-541A7FAA6A66Q36748370-2F54A06C-A8C0-4E4E-8959-7994175C4859Q36808427-E29A82DF-2E7F-4B35-A8EF-8BEE513CD576Q36815482-EF2224F8-AFB3-4931-80FA-89DAA51B1426Q36937839-0E548B76-1D4A-4C90-926C-2A3361B3B83FQ37062967-3EB88346-AD03-43ED-A19C-35179089B25EQ37382604-B3B106CC-1BE9-4121-AC0C-53E5E93EE14DQ37886401-FE5DDA45-2F92-429F-8D9B-999FF5E408C2Q38063499-F62784AA-E57A-4202-BED5-8C5F4BC5BF52Q38221370-9D6C5D7B-22E6-412F-B6DA-2C18A592D9A8Q38733893-D1A02859-38F2-4E1C-B7A8-23403D593678Q38934305-446EECD2-3589-42D8-B41A-0B70C9A1351BQ39166684-6A3E9BD9-E155-4FF7-AAF8-1CEC1C0A1594Q39474660-6BD36ABC-7B0F-45D5-9DCD-09E5643ECA05Q39533226-8AA2571F-C843-43A0-B3C4-C03D17FC18DEQ40028262-E2DD1539-E248-4483-843C-D2F61ADC492BQ41200617-8DF1368C-A0D6-4D83-8637-CF25EA67DB72Q42098333-495E3DA6-1D9E-456D-991B-85CC983AA389Q42709119-8ADC5433-FB70-4C12-9B40-095FC3E15DA7Q42834637-35A4F00A-1F40-4850-87B3-512AD23E3DA4Q46108924-30060A91-D6C3-4083-8E9C-B88C548498A4Q46659361-8BECE23F-7886-49B0-9FEF-26ACF65780D3Q50067937-3E5B2E1A-2FCA-4865-AB33-B80D41A1C719Q51519347-D9C371E9-FBDF-4116-A7F6-6297BA76453DQ53199958-5588B582-71F0-449D-9537-2DD47CF6AF68Q53838915-48618B62-9296-4D35-8EF8-02EFC098A5B5
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Aseptic loosening.
@ast
Aseptic loosening.
@en
type
label
Aseptic loosening.
@ast
Aseptic loosening.
@en
prefLabel
Aseptic loosening.
@ast
Aseptic loosening.
@en
P2860
P356
P1433
P1476
Aseptic loosening.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.GT.3302202
P577
2004-02-01T00:00:00Z